Comment on: Recombinant human TSH in differentiated thyroid cancer: a nuclear medicine perspective

被引：2
|
作者：
Luster, Markus [1 ]
Schlumberger, Martin [2 ]
Pacini, Furio [3 ]
机构：
[1] Univ Ulm, Dept Nucl Med, D-89081 Ulm, Germany
[2] Inst Gustave Roussy, Dept Nucl Med & Endocrine Oncol, F-94805 Villejuif, France
[3] Univ Siena, Sect Endocrinol & Metab, Dept Internal Med, I-53100 Siena, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2009年 / 36卷 / 02期
关键词：
HORMONE WITHDRAWAL; RADIOIODINE THERAPY; MANAGEMENT; CARCINOMA; DOSIMETRY; ABLATION;
D O I：
10.1007/s00259-008-1013-9
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：329 / 330
页数：2
相关论文
共 50 条
  • [1] Radioiodine Therapy in Differentiated Thyroid Cancer: a Nuclear Medicine Perspective
    Clarke, S. E. M.
    CLINICAL ONCOLOGY, 2010, 22 (06) : 430 - 437
  • [2] On the effectiveness of recombinant human TSH as a stimulating agent for 131I treatment of metastatic differentiated thyroid cancer
    Zanotti-Fregonara, Paolo
    Hindie, Elif
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (12) : 2264 - 2266
  • [3] Acute effects of recombinant human TSH on bone markers in differentiated thyroid cancer
    Iakovou, Ioannis
    Chrisoulidou, Alexandra
    Balaris, Vassilis
    Balaris, Christos
    Doumas, Argyrios
    Karatzas, Nikolaos
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2010, 13 (03): : 208 - 212
  • [4] Nuclear Medicine Imaging in Differentiated Thyroid Cancer: Summary of the Korean Thyroid Association Guidelines 2024 from Nuclear Medicine Perspective, Part-I
    Oh, So Won
    Park, Sohyun
    Chong, Ari
    Kim, Keunyoung
    Bang, Ji-In
    Seo, Youngduk
    Hong, Chae Moon
    Lee, Sang-Woo
    NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2025, 59 (01) : 1 - 7
  • [5] I-131 biokinetics of remnant normal thyroid tissue and residual thyroid cancer in patients with differentiated thyroid cancer: comparison between recombinant human TSH administration and thyroid hormone withdrawal
    Hong, Chae Moon
    Kim, Choon-Young
    Son, Seung Hyun
    Jung, Ji-hoon
    Lee, Chang-Hee
    Jeong, Ju Hye
    Jeong, Shin Young
    Lee, Sang-Woo
    Lee, Jaetae
    Ahn, Byeong-Cheol
    ANNALS OF NUCLEAR MEDICINE, 2017, 31 (08) : 582 - 589
  • [6] The Cut-Off Level of Recombinant Human TSH-Stimulated Thyroglobulin in the Follow-Up of Patients with Differentiated Thyroid Cancer
    Kowalska, Aldona
    Palyga, Iwona
    Gasior-Perczak, Danuta
    Walczyk, Agnieszka
    Trybek, Tomasz
    Sluszniak, Anna
    Mezyk, Ryszard
    Gozdz, Stanislaw
    PLOS ONE, 2015, 10 (07):
  • [7] Nuclear medicine therapy of differentiated thyroid cancer: status quo
    Dietlein, M.
    Luster, M.
    Reiners, C.
    ONKOLOGE, 2010, 16 (07): : 678 - +
  • [8] Recombinant Thyrotropin Use in Children and Adolescents with Differentiated Thyroid Cancer: A Multicenter Retrospective Study
    Luster, Markus
    Handkiewicz-Junak, Daria
    Grossi, Armando
    Zacharin, Margaret
    Taieb, David
    Cruz, Ofelia
    Hitzel, Anne
    Vallejo Casas, Juan Antonio
    Maeder, Uwe
    Dottorini, Massimo E.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (10) : 3948 - 3953
  • [9] What role for recombinant human TSH in the treatment of metastatic thyroid cancer?
    Zanotti-Fregonara, Paolo
    Hindie, Elif
    Toubert, Marie Elisabeth
    Rubello, Domenico
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 (06) : 883 - 885
  • [10] Recombinant human TSH versus hypothyroidism Cost-minimization-analysis in the follow-up care of differentiated thyroid carcinoma
    Dietlein, M.
    Busemeyer, S.
    Kobe, C.
    Schmidt, M.
    Theissen, P.
    Schicha, H.
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2010, 49 (06): : 216 - 224
12345